KHRNF - Khiron starts sales in Switzerland expands medical cannabis footprint in UK Germany
- Khiron Life Sciences ( OTCQX:KHRNF ) said it began sales in Switzerland and expanded its product offerings in Germany and the U.K.
- Khiron entered the Swiss medical cannabis market with the first sales of two of its new flower products, KHIRON Gelato 19/1 and THC:CBD balanced flower product KHIRON Caramel 5/7, the company added.
- The company also started sales of three new exclusive products in the U.K., improving selection for patients and prescribers.
- Khiron noted that in Germany, it will start selling seven medical cannabis SKU's in the upcoming weeks, after it gets import approvals from country's regulators.
For further details see:
Khiron starts sales in Switzerland, expands medical cannabis footprint in UK, Germany